Background: The ex vivo mucosal explant model is used to test the efficacy of microbicides that have the potential for preventing HIV-1 transmission. In the colorectal model, biopsies are challenged ex vivo with HIV-1 after study participants are exposed to microbicides in vivo. Product efficacy is assessed by the extent of HIV-1 p24 suppression in supernatant fluids sampled up to Day 14 after HIV-1 challenge. The purpose of this study was to determine if measurement of HIV-1 nucleic acids by real-time PCR and HIV-1 integration by Alu-gag PCR could be used as alternative endpoints in explant studies. Methodology: Twenty rectal biopsies each, from five HIV-1-negative individuals, were placed in culture medium and challenged with 1 x 105 virions/mL of HIV-1BaL for two hours at 37°C. Biopsies were then washed and returned to the tissue culture incubator. Supernatant fluids were collected on days 1, 2, 4, 6, 11 and 14 after infection and viral RNA was extracted (QIAamp Viral RNA Mini kit, Qiagen, Valencia, CA). Individual biopsies were harvested at the same time points and viral nucleic acids were extracted using the AllPrep DNA/RNA mini kit (Qiagen, Valencia, CA). HIV-1 RNA levels were measured by two different real-time PCR assays and a laboratory-developed nested PCR protocol. HIV-1 provirus was measured by real-time PCR assays targeting different regions of the HIV-1 genome as well as nested PCR. Alu-gag PCR followed by real-time PCR of the HIV-1 gag region was used to assess viral integration. Results: Real-time PCR assays detecting HIV-1 DNA and RNA performed similarly provided there were no mismatches between the sequences of the infecting virus and sequences of the assay primers and probes. Viral RNA in supernatant fluids and biopsies could be detected at an earlier time point (Day 4) than HIV-1 provirus (Day 6). A 15 cycle nested PCR step prior to real-time PCR increased assay sensitivity of both HIV-1 RNA and proviral assays while maintaining levels that fell within standard curves. HIV-1 integration using Alu-gag PCR was measurable by day 11 and 14 after infection. Conclusions: Real-time PCR is a sensitive and accurate end point for assessing levels of HIV-1 infection in the ex vivo mucosal explant model. RNA assays are more sensitive than DNA assays all of which coincide with the time course of p24 accumulation in supernatant fluids. Integrated virus is detectable at later time points than viral RNA and DNA in biopsies but is measurable by day 6 after infection in individual biopsies. While HIV-1 viral nucleic acids are detected several days prior to p24, the main advantage of PCR is the smaller sampling size which allows for replicate measurements and thus greater accuracy in detection.